Novo Nordisk A/S
XETRA:NOV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novo Nordisk A/S
XETRA:NOV
|
DK |
|
P
|
Pharol SGPS SA
XBER:PTCA
|
PT |
Intrinsic Value
The intrinsic value for 
Novo Nordisk A/S (NOV) under the Base Case is 67.481 EUR.
Compared with the current market price of 38.205 EUR, the stock appears
Undervalued by 43% .
Both DCF and multiples point to undervaluation.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Novo Nordisk A/S.
Fundamental Analysis
Revenue & Expenses Breakdown
Novo Nordisk A/S
Earnings Waterfall
Novo Nordisk A/S
The intrinsic value for Novo Nordisk A/S (NOV) under the Base Case is 67.481 EUR.
Compared with the current market price of 38.205 EUR, the stock appears Undervalued by 43% .
